These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
276 related articles for article (PubMed ID: 23001567)
21. The von Hippel-Lindau tumor suppressor stabilizes novel plant homeodomain protein Jade-1. Zhou MI; Wang H; Ross JJ; Kuzmin I; Xu C; Cohen HT J Biol Chem; 2002 Oct; 277(42):39887-98. PubMed ID: 12169691 [TBL] [Abstract][Full Text] [Related]
22. Polycystin-1 negatively regulates Polycystin-2 expression via the aggresome/autophagosome pathway. Cebotaru V; Cebotaru L; Kim H; Chiaravalli M; Boletta A; Qian F; Guggino WB J Biol Chem; 2014 Mar; 289(10):6404-6414. PubMed ID: 24459142 [TBL] [Abstract][Full Text] [Related]
23. The von Hippel-Lindau tumor suppressor protein mediates ubiquitination of activated atypical protein kinase C. Okuda H; Saitoh K; Hirai S; Iwai K; Takaki Y; Baba M; Minato N; Ohno S; Shuin T J Biol Chem; 2001 Nov; 276(47):43611-7. PubMed ID: 11574546 [TBL] [Abstract][Full Text] [Related]
24. Polycystin-1 regulates bone development through an interaction with the transcriptional coactivator TAZ. Merrick D; Mistry K; Wu J; Gresko N; Baggs JE; Hogenesch JB; Sun Z; Caplan MJ Hum Mol Genet; 2019 Jan; 28(1):16-30. PubMed ID: 30215740 [TBL] [Abstract][Full Text] [Related]
25. Tat-binding protein-1, a component of the 26S proteasome, contributes to the E3 ubiquitin ligase function of the von Hippel-Lindau protein. Corn PG; McDonald ER; Herman JG; El-Deiry WS Nat Genet; 2003 Nov; 35(3):229-37. PubMed ID: 14556007 [TBL] [Abstract][Full Text] [Related]
27. Steviol stabilizes polycystin 1 expression and promotes lysosomal degradation of CFTR and β-catenin proteins in renal epithelial cells. Yuajit C; Muanprasat C; Homvisasevongsa S; Chatsudthipong V Biomed Pharmacother; 2017 Oct; 94():820-826. PubMed ID: 28802235 [TBL] [Abstract][Full Text] [Related]
28. Beta-catenin gets jaded and von Hippel-Lindau is to blame. Berndt JD; Moon RT; Major MB Trends Biochem Sci; 2009 Mar; 34(3):101-4. PubMed ID: 19217300 [TBL] [Abstract][Full Text] [Related]
29. Polycystin-1 and Gα12 regulate the cleavage of E-cadherin in kidney epithelial cells. Xu JX; Lu TS; Li S; Wu Y; Ding L; Denker BM; Bonventre JV; Kong T Physiol Genomics; 2015 Feb; 47(2):24-32. PubMed ID: 25492927 [TBL] [Abstract][Full Text] [Related]
30. Ubiquitination of a novel deubiquitinating enzyme requires direct binding to von Hippel-Lindau tumor suppressor protein. Li Z; Na X; Wang D; Schoen SR; Messing EM; Wu G J Biol Chem; 2002 Feb; 277(7):4656-62. PubMed ID: 11739384 [TBL] [Abstract][Full Text] [Related]
31. The von Hippel-Lindau tumour suppressor: a multi-faceted inhibitor of tumourigenesis. Barry RE; Krek W Trends Mol Med; 2004 Sep; 10(9):466-72. PubMed ID: 15350900 [No Abstract] [Full Text] [Related]
32. The tuberous sclerosis proteins regulate formation of the primary cilium via a rapamycin-insensitive and polycystin 1-independent pathway. Hartman TR; Liu D; Zilfou JT; Robb V; Morrison T; Watnick T; Henske EP Hum Mol Genet; 2009 Jan; 18(1):151-63. PubMed ID: 18845692 [TBL] [Abstract][Full Text] [Related]
33. Parallel Regulation of von Hippel-Lindau Disease by pVHL-Mediated Degradation of B-Myb and Hypoxia-Inducible Factor α. Okumura F; Uematsu K; Byrne SD; Hirano M; Joo-Okumura A; Nishikimi A; Shuin T; Fukui Y; Nakatsukasa K; Kamura T Mol Cell Biol; 2016 Jun; 36(12):1803-17. PubMed ID: 27090638 [TBL] [Abstract][Full Text] [Related]
34. Hypoxia upregulates von Hippel-Lindau tumor-suppressor protein through RhoA-dependent activity in renal cell carcinoma. Turcotte S; Desrosiers RR; Beliveau R Am J Physiol Renal Physiol; 2004 Feb; 286(2):F338-48. PubMed ID: 14583436 [TBL] [Abstract][Full Text] [Related]
35. Identification of novel VHL target genes and relationship to hypoxic response pathways. Maina EN; Morris MR; Zatyka M; Raval RR; Banks RE; Richards FM; Johnson CM; Maher ER Oncogene; 2005 Jun; 24(28):4549-58. PubMed ID: 15824735 [TBL] [Abstract][Full Text] [Related]
36. Renal cell carcinoma- and pheochromocytoma-specific altered gene expression profiles in VHL mutant clones. Tsuchiya MI; Okuda H; Takaki Y; Baba M; Hirai S; Ohno S; Shuin T Oncol Rep; 2005 Jun; 13(6):1033-41. PubMed ID: 15870918 [TBL] [Abstract][Full Text] [Related]
37. Contrasting effects on HIF-1alpha regulation by disease-causing pVHL mutations correlate with patterns of tumourigenesis in von Hippel-Lindau disease. Clifford SC; Cockman ME; Smallwood AC; Mole DR; Woodward ER; Maxwell PH; Ratcliffe PJ; Maher ER Hum Mol Genet; 2001 May; 10(10):1029-38. PubMed ID: 11331613 [TBL] [Abstract][Full Text] [Related]
38. Hypoxia and cell cycle regulation of the von Hippel-Lindau tumor suppressor. Liu W; Xin H; Eckert DT; Brown JA; Gnarra JR Oncogene; 2011 Jan; 30(1):21-31. PubMed ID: 20802534 [TBL] [Abstract][Full Text] [Related]
39. von Hippel-Lindau protein promotes Skp2 destabilization on DNA damage. Roe JS; Kim HR; Hwang IY; Cho EJ; Youn HD Oncogene; 2011 Jul; 30(28):3127-38. PubMed ID: 21358672 [TBL] [Abstract][Full Text] [Related]